Cargando…

Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution

The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyesung, Kim, Kwangsoon, Bae, Ja Seong, Kim, Jeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360027/
https://www.ncbi.nlm.nih.gov/pubmed/35941209
http://dx.doi.org/10.1038/s41598-022-17979-2
_version_ 1784764263229816832
author Kim, Hyesung
Kim, Kwangsoon
Bae, Ja Seong
Kim, Jeong Soo
author_facet Kim, Hyesung
Kim, Kwangsoon
Bae, Ja Seong
Kim, Jeong Soo
author_sort Kim, Hyesung
collection PubMed
description The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients who underwent thyroid surgery for T2 PTC from January 2009 to December 2014 at Seoul St. Mary’s Hospital (Seoul, Korea). The mean follow-up duration was 100.7 months. Eleven (4.4%) patients had recurrence. The recurrence rates did not significantly differ in terms of the extent of surgery (p = 0.868). Patients with a high lymph node ratio (LNR) had a significantly higher recurrence rate than those with a low LNR (p < 0.001). According to a recurrence pattern analysis, five of six patients in the lobectomy group had recurrence in the ipsilateral lateral compartment. A multivariate analysis revealed that a high LNR was a significant risk factor for recurrence (hazard ratio: 11.025, p = 0.002). Our results suggest that patients without clinical evidence of any lymph node metastases and those with limited lesions in the thyroid gland can undergo lobectomy and LNR can serve as an independent risk factor for predicting recurrence in T2 PTC.
format Online
Article
Text
id pubmed-9360027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93600272022-08-10 Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution Kim, Hyesung Kim, Kwangsoon Bae, Ja Seong Kim, Jeong Soo Sci Rep Article The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients who underwent thyroid surgery for T2 PTC from January 2009 to December 2014 at Seoul St. Mary’s Hospital (Seoul, Korea). The mean follow-up duration was 100.7 months. Eleven (4.4%) patients had recurrence. The recurrence rates did not significantly differ in terms of the extent of surgery (p = 0.868). Patients with a high lymph node ratio (LNR) had a significantly higher recurrence rate than those with a low LNR (p < 0.001). According to a recurrence pattern analysis, five of six patients in the lobectomy group had recurrence in the ipsilateral lateral compartment. A multivariate analysis revealed that a high LNR was a significant risk factor for recurrence (hazard ratio: 11.025, p = 0.002). Our results suggest that patients without clinical evidence of any lymph node metastases and those with limited lesions in the thyroid gland can undergo lobectomy and LNR can serve as an independent risk factor for predicting recurrence in T2 PTC. Nature Publishing Group UK 2022-08-08 /pmc/articles/PMC9360027/ /pubmed/35941209 http://dx.doi.org/10.1038/s41598-022-17979-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kim, Hyesung
Kim, Kwangsoon
Bae, Ja Seong
Kim, Jeong Soo
Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title_full Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title_fullStr Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title_full_unstemmed Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title_short Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
title_sort clinical assessment of t2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360027/
https://www.ncbi.nlm.nih.gov/pubmed/35941209
http://dx.doi.org/10.1038/s41598-022-17979-2
work_keys_str_mv AT kimhyesung clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution
AT kimkwangsoon clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution
AT baejaseong clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution
AT kimjeongsoo clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution